For the Inventor, By the Inventor

Enter inventor name

Reinheim, Germany

Norbert Beier

USPTO Granted Patents = 69 (Patent Applications = 4)

CIPO Patents = 5

EPO Patents = 23 (Patent Applications = 14)

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 483(Granted Patents)

Forward Citations (Not Self Cited) = 454(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

36 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

27 out of 2,943

Merck Patent Gmbh

Merck Patent Gesellschaft MIT Beschraenkter Haftung

4. 2 out of 121

Merck Patent Gesellschaft

Meck Patent Gmbh

Years Active: 1992-2019

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Pharmaceutical Composition

Insulin Resistance

Beta-Amino Acid Derivatives

Glucokinase Activators

SGLT Inhibitors

Heterocyclic Compounds

Diabetes Treatment

Kinase Inhibitors

Oxadiazole Derivatives

Indazole Derivatives

Pyrimidine Derivatives

Thienopyrimidines

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10292949 - Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and β-cell dysfunction (2019-05-21),

2. 8815924 - Heterocyclic carbonyl compounds (2014-08-26),

3. 8546613 - SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas (2013-10-01),

4. 8492440 - Difluorophenyldiacylhydrazide derivatives (2013-07-23),

5. 8431602 - Beta-amino acid derivatives for treatment of diabetes (2013-04-30),

6. 8420642 - Pyridine derivatives useful as glucokinase activators (2013-04-16),

7. 8399509 - Glucopyranoside derivatives (2013-03-19),

8. 8383838 - 5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 (2013-02-26),

9. 8377975 - Oxadiazole derivatives for the treatment of diabetes (2013-02-19),

10. 8334309 - Heterocyclic indazole derivatives (2012-12-18),

11. 8278312 - [object Object] (2012-10-02),

12. 8258151 - 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors (2012-09-04),

13. 8236824 - N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators (2012-08-07),

14. 8207210 - Aminoindazolylurea derivatives (2012-06-26),

15. 8153649 - 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes (2012-04-10),

Title: Norbert Beier - Innovative Inventor from Reinheim

Introduction: Norbert Beier is a renowned inventor hailing from Reinheim, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Norbert Beier holds several patents in various technological domains, including advancements in renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights: Throughout his illustrious career, Norbert Beier has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Norbert Beier has collaborated with top engineers, scientists, and inventors to bring his visionary ideas to life, resulting in successful products and technologies that have had a lasting impact on society.

Conclusion: Norbert Beier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…